EMA Report on Clinical Trials outside the EU
"The European Medicines Agency published a meeting report reflecting discussions and comments made on its draft reflection paper on ethical and good-clinical-practice (GCP) aspects of clinical trials of medicinal products for human use conducted in third countries and submitted in marketing authorisation applications to the European Medicines Agency.
The discussions took place during an international workshop held in September 2010.
The workshop, which brought together 140 European and international participants from 43 countries, represents part of the public consultation process on the reflection paper.
All comments received during the workshop and in writing as part of the public consultation are currently being reviewed before the final version of the reflection paper is agreed and published later this year.
The slides from the presentations given during the workshop are also available to download."
Source: EMA press release
Related GMP News
03.04.2025Update on the ICH M11 CeSHArP Technical Specification
03.04.2025EU Map to Clinical Trials
03.04.2025EMA Concept Paper on Model Informed Drug Development
20.03.2025End of the Transition Period for Clinical Trials
11.02.2025Final ICH E6(R3) Guideline on GCP released
11.02.2025FDA issues Draft Guidance on Handling Protocol Deviations in Clinical Trials